However, immunohistochemical studies have demonstrated expression of CD133 not only in perivascular niches, but also in hypoxic regions [19, 20], supporting the idea that GSCs may also populate hypoxic microenvironments in GBM. This evidence concerns the gene PROM1 and glioblastoma.